Click Here to return To Results

 

Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome NEJM 376:2341-2348, Kraft, W.K.,et al, 2017 See this aricle in Pubmed Article Abstract Among infants with the neonatal abstinence syndrome, treatment with sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than treatment with oral morphine, with similar rates of adverse events.

Related Tags

(click to filter results - removes previous filter) buprenorphine drug withdrawal hospital length of stay neonatal abstinence syndrome opiate seizure,withdrawal sublingual treatment of neurologic disorder

Click Here to return To Results